137 related articles for article (PubMed ID: 6991152)
1. Peripheral dopamine receptors.
Clark BJ; Menninger K
Circ Res; 1980 Jun; 46(6 Pt 2):I59-63. PubMed ID: 6991152
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptors and the cardiovascular system.
Clark BJ
Postgrad Med J; 1981; 57 Suppl 1():45-54. PubMed ID: 6117848
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic dopamine receptor stimulation in the cardiovascular actions of lergotrile.
Barrett RJ; Lokhandwala MF
J Pharmacol Exp Ther; 1981 Jun; 217(3):660-5. PubMed ID: 6112262
[TBL] [Abstract][Full Text] [Related]
4. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
Amenta F; Ricci A; Tayebati SK; Zaccheo D
Ital J Anat Embryol; 2002; 107(3):145-67. PubMed ID: 12437142
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
Hahn RA; Wardell JR; Sarau HM; Ridley PT
J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
[TBL] [Abstract][Full Text] [Related]
6. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers.
Hom GJ; Jandhyala BS
J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
Itoh H; Kohli JD; Rajfer SI; Goldberg LI
J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
Cavero I; Lefèvre-Borg F; Gomeni R
J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
[TBL] [Abstract][Full Text] [Related]
9. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
Ensinger H; Majewski H; Hedler L; Starke K
J Pharmacol Exp Ther; 1985 Sep; 234(3):681-90. PubMed ID: 2993590
[TBL] [Abstract][Full Text] [Related]
10. Renal hemodynamics in hemorrhagic hypotension: studies on the effects of pre- and postjunctional dopamine receptor agonists.
Hamed AT; Ginos JZ; Ekas RD; Jandhyala BS; Lokhandwala MF
J Cardiovasc Pharmacol; 1983; 5(2):207-12. PubMed ID: 6188891
[TBL] [Abstract][Full Text] [Related]
11. The role of sympathetic nervous system in the vascular actions of dopamine.
Lokhandwala MF; Jandhyala BS
J Pharmacol Exp Ther; 1979 Jul; 210(1):120-6. PubMed ID: 36477
[No Abstract] [Full Text] [Related]
12. Dopamine: vascular and renal effects and alterations in hypertension.
Elghozi JL; Earnhardt JT; Meyer P
Adv Nephrol Necker Hosp; 1984; 13():135-50. PubMed ID: 6433664
[No Abstract] [Full Text] [Related]
13. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
14. Stereoselectivity of S- and R-sulpiride for pre- and postsynaptic dopamine receptors in the canine kidney.
Bass AS; Robie NW
J Pharmacol Exp Ther; 1984 Apr; 229(1):67-71. PubMed ID: 6707948
[TBL] [Abstract][Full Text] [Related]
15. Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats.
Polakowski JS; Segreti JA; Cox BF; Hsieh GC; Kolasa T; Moreland RB; Brioni JD
Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):837-41. PubMed ID: 15659045
[TBL] [Abstract][Full Text] [Related]
16. The role of sympathetic nervous system in the action of dopamine and dobutamine on the function of circulatory system.
Krawczak J; Beutler A; Kozłowska T; Olejnik A
Pol J Pharmacol Pharm; 1989; 41(6):639-48. PubMed ID: 2485908
[TBL] [Abstract][Full Text] [Related]
17. Facilitation of ganglionic transmission by sulpiride: evidence for an inhibitory role of dopamine in the canine sympathetic ganglion.
Horn PT; Kohli JD; Goldberg LI
J Pharmacol Exp Ther; 1982 Nov; 223(2):462-8. PubMed ID: 6290639
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the sympathetic nervous system by 5,6-dihydroxy-2-dimethylamino tetralin (M-7), apomorphine and dopamine.
Long JP; Heintz S; Cannon JG; Kim J
J Pharmacol Exp Ther; 1975 Feb; 192(2):336-42. PubMed ID: 1117421
[TBL] [Abstract][Full Text] [Related]
19. The effect of dopamine on blood flow in skeletal muscles.
Krawczak J; Kozłowska T; Wasik-Olejnik A; Beutler A; Chodera A
Pol J Pharmacol Pharm; 1988; 40(2):145-54. PubMed ID: 3237564
[TBL] [Abstract][Full Text] [Related]
20. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors.
Lokhandwala MF; Buckley JP
J Pharmacol Exp Ther; 1978 Feb; 204(2):362-71. PubMed ID: 621670
[No Abstract] [Full Text] [Related]
[Next] [New Search]
